Protagenic Therapeutics (PTIX) — Cash Flow-to-Debt Ratio
Protagenic Therapeutics (PTIX) has a Cash Flow-to-Debt Ratio of -0.06x as of December 2025, meaning its operating cash flow of $-410.42K could theoretically repay 0% of its total liabilities ($6.82 Million) in one year. Check PTIX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Protagenic Therapeutics Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Protagenic Therapeutics across 31 annual periods. Also explore PTIX asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Protagenic Therapeutics (1995–2025)
Year-by-year debt coverage analysis for Protagenic Therapeutics. For market capitalisation and broader financial context, see PTIX company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.61x | $-4.14 Million | $6.82 Million | ▲ +86.4% |
| 2024 | -4.47x | $-4.22 Million | $942.76K | ▲ +20.9% |
| 2023 | -5.65x | $-3.70 Million | $655.25K | ▼ -217.5% |
| 2022 | -1.78x | $-1.99 Million | $1.12 Million | ▲ +28.9% |
| 2021 | -2.50x | $-2.80 Million | $1.12 Million | ▼ -276.6% |
| 2020 | -0.66x | $-1.35 Million | $2.03 Million | ▼ -101.2% |
| 2019 | -0.33x | $-487.99K | $1.48 Million | ▲ +72.0% |
| 2018 | -1.18x | $-1.07 Million | $907.77K | ▲ +52.0% |
| 2017 | -2.46x | $-1.38 Million | $561.69K | ▼ -47.6% |
| 2016 | -1.67x | $-1.14 Million | $684.86K | ▼ -210.1% |
| 2015 | -0.54x | $-378.00K | $704.00K | ▲ +10.5% |
| 2015 | -0.60x | $-378.00K | $630.00K | ▲ +76.0% |
| 2014 | -2.50x | $-790.00K | $316.00K | ▲ +0.0% |
| 2013 | -2.50x | $-790.00K | $316.00K | ▼ -13927.8% |
| 2012 | -0.02x | $-324.00K | $18.18 Million | ▲ +98.2% |
| 2010 | -1.01x | $-11.25 Million | $11.17 Million | ▼ -543.1% |
| 2009 | -0.16x | $-3.02 Million | $19.25 Million | ▼ -186.7% |
| 2008 | 0.18x | $4.36 Million | $24.11 Million | ▲ +124.6% |
| 2007 | -0.73x | $-5.21 Million | $7.10 Million | ▼ -436.7% |
| 2006 | 0.22x | $931.00K | $4.27 Million | ▲ +146.8% |
| 2005 | -0.47x | $-44.00K | $94.47K | ▼ -133.2% |
| 2004 | -0.20x | $-842.00K | $4.21 Million | ▼ -193.6% |
| 2003 | 0.21x | $1.87 Million | $8.76 Million | ▼ -21.2% |
| 2002 | 0.27x | $2.35 Million | $8.65 Million | ▲ +74.9% |
| 2001 | 0.15x | $1.50 Million | $9.71 Million | ▼ -60.0% |
| 2000 | 0.39x | $3.51 Million | $9.06 Million | ▲ +1029.6% |
| 1999 | 0.03x | $331.00K | $9.66 Million | ▲ +159.5% |
| 1998 | -0.06x | $-434.00K | $7.53 Million | ▲ +93.5% |
| 1997 | -0.89x | $-2.20 Million | $2.47 Million | ▼ -2042.5% |
| 1996 | -0.04x | $-230.00K | $5.53 Million | ▲ +75.3% |
| 1995 | -0.17x | $-600.00K | $3.57 Million | — |